#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	11010	16S	1529	1529	99.87	16S.l6.c30.ctg.1	2088	856.1	0	.	n	.	0	A69G	SNP	69	69	A	451	451	G	953	G,T	544,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	11010	16S	1529	1529	99.87	16S.l6.c30.ctg.1	2088	856.1	0	.	n	.	0	C1450T	SNP	1450	1450	C	1832	1832	T	1012	T,G	546,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	11010	16S	1529	1529	99.87	16S.l6.c30.ctg.1	2088	856.1	1	SNP	n	C1184T	0	.	.	1184	1184	C	1566	1566	C	1106	C,T	608,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	20140	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3391	939.5	0	.	n	.	0	G1337A	SNP	1337	1337	G	1628	1628	A	1000	A	557	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	20140	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3391	939.5	0	.	n	.	0	T1971C	SNP	1971	1971	T	2262	2262	C	916	C	519	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	20140	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3391	939.5	0	.	n	.	0	A2279G	SNP	2279	2279	A	2570	2570	G	878	G,A,T	352,134,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	20140	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3391	939.5	1	SNP	n	A2045G	0	.	.	2045	2045	A	2336	2336	A	1073	A	603	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	20140	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3391	939.5	1	SNP	n	C2597T	0	.	.	2597	2597	C	2888	2888	C	1017	C,A	569,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_K_01359c	folP.WHO_K_01359c	1	1	539	718	folP	852	852	99.88	folP.l15.c4.ctg.1	1454	83.8	0	.	p	.	0	E151K	NONSYN	451	453	GAA	702	704	AAA	137;140;140	A;A;A	76;80;77	.	.
folP.WHO_K_01359c	folP.WHO_K_01359c	1	1	539	718	folP	852	852	99.88	folP.l15.c4.ctg.1	1454	83.8	1	SNP	p	R228S	1	.	.	682	684	AGC	933	935	AGC	128;130;129	A;G;C	75;74;78	folP.WHO_K_01359c:1:1:R228S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	2368	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3501	109.5	1	SNP	p	S91F	0	.	.	271	273	TCC	634	636	TCC	164;164;164	T,C;C;C	97,1;94;95	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	2368	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3501	109.5	1	SNP	p	D95G	0	.	.	283	285	GAC	646	648	GAC	170;175;175	G;A;C	97;99;102	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	2368	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3501	109.5	1	SNP	p	D95N	0	.	.	283	285	GAC	646	648	GAC	170;175;175	G;A;C	97;99;102	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_V_01454	mtrR.WHO_V_01454	1	1	27	634	mtrR	633	633	100.0	mtrR.l6.c4.ctg.1	1035	104.7	1	SNP	p	G45D	0	.	.	133	135	GGC	334	336	GGC	180;181;181	G;G;C	100;100;100	mtrR.WHO_V_01454:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	432	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	835	84.8	0	.	n	.	0	A197.	DEL	197	197	A	403	403	A	180	A	103	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	2128	parC	2304	2304	99.91	parC.l15.c4.ctg.1	2676	129.2	1	SNP	p	D86N	0	.	.	256	258	GAC	437	439	GAC	178;178;180	G;A;C	105;99;105	parC.WHO_M_00204c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	2128	parC	2304	2304	99.91	parC.l15.c4.ctg.1	2676	129.2	1	SNP	p	S87I	0	.	.	259	261	AGT	440	442	AGT	177;181;183	A;G;T	98;105;109	parC.WHO_M_00204c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	2128	parC	2304	2304	99.91	parC.l15.c4.ctg.1	2676	129.2	1	SNP	p	S87R	0	.	.	259	261	AGT	440	442	AGT	177;181;183	A;G;T	98;105;109	parC.WHO_M_00204c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	2128	parC	2304	2304	99.91	parC.l15.c4.ctg.1	2676	129.2	1	SNP	p	S87W	0	.	.	259	261	AGT	440	442	AGT	177;181;183	A;G;T	98;105;109	parC.WHO_M_00204c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	2128	parC	2304	2304	99.91	parC.l15.c4.ctg.1	2676	129.2	1	SNP	p	S88P	0	.	.	262	264	TCC	443	445	TCC	183;182;178	T;C;C	104;102;103	parC.WHO_M_00204c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	1934	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2420	129.5	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1489	1491	GGC	100;100;100	G;G;C	62;64;58	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.9.001	penA.9.001	1	1	527	2078	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2263	139.0	1	SNP	p	A311V	0	.	.	931	933	GCA	1141	1143	GCA	192;195;195	G;C;A	106;111;113	penA.9.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	527	2078	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2263	139.0	1	SNP	p	I312M	0	.	.	934	936	ATC	1144	1146	ATC	199;199;199	A;T;C	113;114;112	penA.9.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	527	2078	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2263	139.0	1	SNP	p	V316P	0	.	.	946	948	GTG	1156	1158	GTG	213;213;213	G;T;G	123;119;119	penA.9.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	527	2078	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2263	139.0	1	SNP	p	V316T	0	.	.	946	948	GTG	1156	1158	GTG	213;213;213	G;T;G	123;119;119	penA.9.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	527	2078	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2263	139.0	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1660	1662	ACC	118;118;113	A;C;C	64;68;64	penA.9.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	527	2078	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2263	139.0	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1714	1716	GCG	93;93;93	G;C;G	51;48;49	penA.9.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	527	2078	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2263	139.0	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1714	1716	GCG	93;93;93	G;C;G	51;48;49	penA.9.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	527	2078	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2263	139.0	1	SNP	p	G543S	0	.	.	1627	1629	GGC	1837	1839	GGC	81;81;84	G;G;C	52;52;52	penA.9.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	527	2078	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2263	139.0	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1846	1848	GGC	74;75;74	G;G,T;C	48;50,1;44	penA.9.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	527	2078	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2263	139.0	1	SNP	p	L552S	0	.	.	1654	1656	CTG	1864	1866	CTG	72;70;70	C;T,C;G	42;37,1;34	penA.9.001:1:1:L552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	527	2078	penA	1749	199	98.99	penA.l6.c4.ctg.2	495	4.3	0	.	p	.	0	R288S	NONSYN	862	864	AGA	301	303	AGC	2;2;2	A;G;C,A	1;1;0,1	.	.
penA.9.001	penA.9.001	1	1	527	2078	penA	1749	199	98.99	penA.l6.c4.ctg.2	495	4.3	0	.	p	.	0	A301S	NONSYN	901	903	GCC	340	342	TCC	4;4;4	T,G;C;C	0,2;2;2	.	.
penA.9.001	penA.9.001	1	1	527	2078	penA	1749	199	98.99	penA.l6.c4.ctg.2	495	4.3	1	SNP	p	A311V	0	.	.	931	933	GCA	370	372	GCA	6;6;6	G;C;A	3;3;3	penA.9.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	527	2078	penA	1749	199	98.99	penA.l6.c4.ctg.2	495	4.3	1	SNP	p	I312M	0	.	.	934	936	ATC	373	375	ATC	6;6;6	A;T;C	3;3;3	penA.9.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	527	2078	penA	1749	199	98.99	penA.l6.c4.ctg.2	495	4.3	1	SNP	p	V316P	0	.	.	946	948	GTG	385	387	GTG	10;10;10	G;T;G	5;5;5	penA.9.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	527	2078	penA	1749	199	98.99	penA.l6.c4.ctg.2	495	4.3	1	SNP	p	V316T	0	.	.	946	948	GTG	385	387	GTG	10;10;10	G;T;G	5;5;5	penA.9.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	527	2078	penA	1749	197	95.94	penA.l6.c4.ctg.3	524	1.8	0	.	p	.	0	K4Q	NONSYN	10	12	AAA	65	67	CAA	2;2;2	C;A;A	0;0;0	.	.
penA.9.001	penA.9.001	1	1	527	2078	penA	1749	197	95.94	penA.l6.c4.ctg.3	524	1.8	0	.	p	.	0	E6G	NONSYN	16	18	GAA	71	73	GGA	2;2;4	G;G;A	0;0;1	.	.
penA.9.001	penA.9.001	1	1	527	2078	penA	1749	197	95.94	penA.l6.c4.ctg.3	524	1.8	0	.	p	.	0	R10G	NONSYN	28	30	CGG	83	85	GGG	4;4;4	G,C;G;G	0,1;1;1	.	.
penA.9.001	penA.9.001	1	1	527	2078	penA	1749	197	95.94	penA.l6.c4.ctg.3	524	1.8	0	.	p	.	0	N25T	NONSYN	73	75	AAC	128	130	ACC	4;4;4	A;C,A;C	1;0,1;1	.	.
penA.9.001	penA.9.001	1	1	527	2078	penA	1749	197	95.94	penA.l6.c4.ctg.3	524	1.8	0	.	p	.	0	V37D	NONSYN	109	111	GTC	164	166	GAC	4;4;4	G;A,T;C	1;0,1;1	.	.
penA.9.001	penA.9.001	1	1	527	2078	penA	1749	197	95.94	penA.l6.c4.ctg.3	524	1.8	0	.	p	.	0	A44D	NONSYN	130	132	GCC	185	187	GAC	4;4;4	G;A,C;C	1;0,1;1	.	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	527	3588	ponA	2397	2397	100.0	ponA.l6.c4.ctg.1	2921	181.2	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1544	1546	CCG	132;132;133	C;C;G	77;82;79	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	527	3588	ponA	2397	300	90.33	ponA.l6.c4.ctg.2	488	0.9	0	.	p	.	0	D348E	NONSYN	1042	1044	GAT	95	97	GAA	1;1;1	G;A;A,T	1;1;0,1	.	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	527	3588	ponA	2397	300	90.33	ponA.l6.c4.ctg.2	488	0.9	0	.	p	.	0	K349N	NONSYN	1045	1047	AAA	98	100	AAT	1;1;1	A;A;T,A	1;1;0,1	.	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	527	3588	ponA	2397	300	90.33	ponA.l6.c4.ctg.2	488	0.9	0	.	p	.	0	M350V	NONSYN	1048	1050	ATG	101	103	GTG	1;1;1	G,A;T;G	0,1;1;1	.	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	527	3588	ponA	2397	300	90.33	ponA.l6.c4.ctg.2	488	0.9	0	.	p	.	0	L356W	NONSYN	1066	1068	TTG	119	121	TGG	2;2;2	T;G,T;G	1;0,1;1	.	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	527	3588	ponA	2397	300	90.33	ponA.l6.c4.ctg.2	488	0.9	0	.	p	.	0	D377A	NONSYN	1129	1131	GAC	182	184	GCC	2;2;2	G;C,A;C	1;0,1;1	.	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	527	3588	ponA	2397	300	90.33	ponA.l6.c4.ctg.2	488	0.9	0	.	p	.	0	R379G	NONSYN	1135	1137	CGC	188	190	GGC	2;2;2	G,C;G;C	0,1;1;1	.	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	527	3588	ponA	2397	300	90.33	ponA.l6.c4.ctg.2	488	0.9	0	.	p	.	0	V415G	NONSYN	1243	1245	GTG	296	298	GGG	2;2;2	G;G,T;G	1;0,1;1	.	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	527	3588	ponA	2397	300	90.33	ponA.l6.c4.ctg.2	488	0.9	0	.	p	.	0	E418N	NONSYN	1252	1254	GAG	305	307	AAT	1;1;1	A,G;A;T,G	0,1;1;0,1	.	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	527	3588	ponA	2397	300	90.33	ponA.l6.c4.ctg.2	488	0.9	0	.	p	.	0	P419R	NONSYN	1255	1257	CCG	308	310	CGG	1;1;1	C;G,C;G	1;0,1;1	.	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	527	3588	ponA	2397	300	90.33	ponA.l6.c4.ctg.2	488	0.9	0	.	p	.	0	L420V	NONSYN	1258	1260	TTG	311	313	GTG	1;1;1	G,T;T;G	0,1;1;1	.	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	527	3588	ponA	2397	300	90.33	ponA.l6.c4.ctg.2	488	0.9	0	.	p	.	0	Q422P	NONSYN	1264	1266	CAG	317	319	CCA	0;1;1	C;C;A	0;0;1	.	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	527	3588	ponA	2397	300	90.33	ponA.l6.c4.ctg.2	488	0.9	0	.	p	.	0	L428P	NONSYN	1282	1284	CTG	335	337	CCA	ND;ND;ND	ND;ND;ND	ND;ND;ND	.	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	527	3588	ponA	2397	300	90.33	ponA.l6.c4.ctg.2	488	0.9	0	.	p	.	0	G433W	NONSYN	1297	1299	GGA	350	352	TGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	.	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	527	3588	ponA	2397	300	90.33	ponA.l6.c4.ctg.2	488	0.9	0	.	p	.	0	V435L	NONSYN	1303	1305	GTG	356	358	CTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	.	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	527	3588	ponA	2397	300	90.33	ponA.l6.c4.ctg.2	488	0.9	0	.	p	.	0	L438V	NONSYN	1312	1314	CTG	365	367	GTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	.	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	527	3588	ponA	2397	300	90.33	ponA.l6.c4.ctg.2	488	0.9	0	.	p	.	0	Y442trunc	TRUNC	1324	1324	T	377	377	T	ND	ND	ND	.	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	527	3588	ponA	2397	300	90.33	ponA.l6.c4.ctg.2	488	0.9	1	SNP	p	L421P	1	.	.	1261	1263	CCG	314	316	CCG	1;1;1	C;C;G	1;1;1	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	966	porA	1146	1146	99.65	porA.l15.c17.ctg.1	1440	108.9	0	.	p	.	0	M83fs	FSHIFT	247	247	A	377	377	C	64	C	35	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	100	porB1a	984	112	91.96	porB1a.l15.c4.ctg.1	359	34.4	0	.	p	.	0	M18T	NONSYN	52	54	ATG	272	274	ACG	51;47;47	A;C;G	28;26;25	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	100	porB1a	984	112	91.96	porB1a.l15.c4.ctg.1	359	34.4	0	.	p	.	0	E32Q	NONSYN	94	96	GAA	314	316	CAA	25;25;25	C;A;A,C	16;15;16,1	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	100	porB1a	984	112	91.96	porB1a.l15.c4.ctg.1	359	34.4	0	.	p	.	0	S34Y	NONSYN	100	102	TCC	320	322	TAC	18;17;17	T,G;A;C	11,1;11;10	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	1330	porB1b	1047	1047	99.24	porB1b.l15.c4.ctg.1	1585	133.8	0	.	p	.	0	N38E	NONSYN	112	114	AAT	407	409	GAA	166;161;165	G;A;A	99;97;98	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	1330	porB1b	1047	1047	99.24	porB1b.l15.c4.ctg.1	1585	133.8	0	.	p	.	0	N134D	NONSYN	400	402	AAT	695	697	GAT	152;157;157	G;A;T	91;94;93	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	1330	porB1b	1047	1047	99.24	porB1b.l15.c4.ctg.1	1585	133.8	0	.	p	.	0	P175S	NONSYN	523	525	CCA	818	820	TCA	213;214;214	T;C;A	122;120;122	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	1330	porB1b	1047	1047	99.24	porB1b.l15.c4.ctg.1	1585	133.8	0	.	p	.	0	A218V	NONSYN	652	654	GCC	947	949	GTC	122;122;120	G;T;C	66;69;68	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	1330	porB1b	1047	1047	99.24	porB1b.l15.c4.ctg.1	1585	133.8	0	.	p	.	0	F222S	NONSYN	664	666	TTT	959	961	TCT	104;104;104	T;C;T	57;59;59	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	1330	porB1b	1047	1047	99.24	porB1b.l15.c4.ctg.1	1585	133.8	0	.	p	.	0	E328A	NONSYN	982	984	GAA	1277	1279	GCA	182;181;174	G;C;A,C	98;100;97,1	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	1330	porB1b	1047	1047	99.24	porB1b.l15.c4.ctg.1	1585	133.8	1	SNP	p	G120K	1	.	.	358	360	AAG	653	655	AAG	173;173;173	A;A;G,T	100;102;103,1	porB1b.WHO_V_02265c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	1330	porB1b	1047	1047	99.24	porB1b.l15.c4.ctg.1	1585	133.8	1	SNP	p	A121D	1	.	.	361	363	GAC	656	658	GAC	174;174;174	G;A,C;C	102;96,1;97	porB1b.WHO_V_02265c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	1330	porB1b	1047	1047	99.24	porB1b.l15.c4.ctg.1	1585	133.8	1	SNP	p	D121N	0	.	.	361	363	GAC	656	658	GAC	174;174;174	G;A,C;C	102;96,1;97	porB1b.WHO_V_02265c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	58	porB3	990	205	92.68	porB3.l15.c4.ctg.2	208	8.3	0	.	p	.	0	L253A	NONSYN	757	759	TTG	39	41	GCG	2;2;2	G;C;G	1;1;1	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	58	porB3	990	205	92.68	porB3.l15.c4.ctg.2	208	8.3	0	.	p	.	0	V260L	NONSYN	778	780	GTA	60	62	TTA	4;4;4	T;T;A	2;2;2	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	58	porB3	990	205	92.68	porB3.l15.c4.ctg.2	208	8.3	0	.	p	.	0	D275H	NONSYN	823	825	GAT	105	107	CAT	10;10;10	C;A;T	6;5;6	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	58	porB3	990	205	92.68	porB3.l15.c4.ctg.2	208	8.3	0	.	p	.	0	D276S	NONSYN	826	828	GAT	108	110	AGT	10;10;10	A;G;T,G	6;6;5,1	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	58	porB3	990	205	92.68	porB3.l15.c4.ctg.2	208	8.3	0	.	p	.	0	K278D	NONSYN	832	834	AAA	114	116	GAC	10;10;10	G;A;C	5;4;5	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	58	porB3	990	205	92.68	porB3.l15.c4.ctg.2	208	8.3	0	.	p	.	0	R279Y	NONSYN	835	837	CGC	117	119	TAC	10;10;10	T;A;C	4;4;4	.	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	539	5704	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4602	202.2	1	SNP	p	H553N	1	H553N	NONSYN	1657	1659	CAT	1826	1828	AAT	219;218;218	A;A,C;T	135;131,1;133	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	438	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1132	63.4	1	SNP	p	V57M	1	.	.	169	171	ATG	594	596	ATG	143;139;143	A,C;T;G	82,1;79;83	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
